secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-PATH HOLDINGS, INC. (BPTH)
CIK:        0001133818
Form:       8-K
Filed at:   2024-03-13T23:59:59+00:00
Accession:  0001558370-24-003118
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Path receives Nasdaq delisting notice for failing $2.5M equity minimum
--------------------------------------------------------------------------

- Deficiency letter received March 12, 2024 citing non-compliance with Nasdaq Listing Rule 5550(b)(1).
- Company has until April 26, 2024 to submit a plan to regain compliance.
- If plan accepted, Nasdaq may grant up to 180 days extension to cure deficiency.
- Common stock continues trading on Nasdaq Capital Market under symbol BPTH pending review.
- Company evaluating options but no assurance of regaining compliance or avoiding delisting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133818/000155837024003118/0001558370-24-003118-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133818/000155837024003118/bpth-20240312x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-003118

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer